101 related articles for article (PubMed ID: 29547762)
1. The utility of the Total Neuropathy Score as an instrument to assess neuropathy severity in chronic kidney disease: A validation study.
Issar T; Arnold R; Kwai NCG; Pussell BA; Endre ZH; Poynten AM; Kiernan MC; Krishnan AV
Clin Neurophysiol; 2018 May; 129(5):889-894. PubMed ID: 29547762
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of vincristine-induced peripheral neuropathy in children with cancer: Turkish validity and reliability study.
Özdemir B; Gerçeker GÖ; Özdemir EZ; Yildirim BG; Ören H; Yiş U; Günay Ç; Thomas GÖ
J Pediatr Nurs; 2023; 72():185-190. PubMed ID: 37076371
[TBL] [Abstract][Full Text] [Related]
3. Total neuropathy score: validation and reliability study.
Cornblath DR; Chaudhry V; Carter K; Lee D; Seysedadr M; Miernicki M; Joh T
Neurology; 1999 Nov; 53(8):1660-4. PubMed ID: 10563609
[TBL] [Abstract][Full Text] [Related]
4. Measuring vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.
Lavoie Smith EM; Li L; Hutchinson RJ; Ho R; Burnette WB; Wells E; Bridges C; Renbarger J
Cancer Nurs; 2013; 36(5):E49-60. PubMed ID: 23842524
[TBL] [Abstract][Full Text] [Related]
5. In Search of a Gold Standard Patient-Reported Outcome Measure for Use in Chemotherapy- Induced Peripheral Neuropathy Clinical Trials.
Smith EML; Knoerl R; Yang JJ; Kanzawa-Lee G; Lee D; Bridges CM
Cancer Control; 2018; 25(1):1073274818756608. PubMed ID: 29480026
[TBL] [Abstract][Full Text] [Related]
6. Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy.
Bastyr EJ; Price KL; Bril V;
Clin Ther; 2005 Aug; 27(8):1278-94. PubMed ID: 16199253
[TBL] [Abstract][Full Text] [Related]
7. Peripheral neuropathy: an important contributor to physical limitation and morbidity in stages 3 and 4 chronic kidney disease.
Arnold R; Pianta TJ; Issar T; Kirby A; Scales CMK; Kwai NCG; Endre Z; Krishnan AV
Nephrol Dial Transplant; 2022 Mar; 37(4):713-719. PubMed ID: 33576810
[TBL] [Abstract][Full Text] [Related]
8. The reliability and validity of a modified total neuropathy score-reduced and neuropathic pain severity items when used to measure chemotherapy-induced peripheral neuropathy in patients receiving taxanes and platinums.
Smith EM; Cohen JA; Pett MA; Beck SL
Cancer Nurs; 2010; 33(3):173-83. PubMed ID: 20357656
[TBL] [Abstract][Full Text] [Related]
9. Public knowledge of chronic kidney disease evaluated using a validated questionnaire: a cross-sectional study.
Gheewala PA; Peterson GM; Zaidi STR; Jose MD; Castelino RL
BMC Public Health; 2018 Mar; 18(1):371. PubMed ID: 29554891
[TBL] [Abstract][Full Text] [Related]
10. The reliability and validity of the subjective peripheral neuropathy screen.
McArthur JH
J Assoc Nurses AIDS Care; 1998; 9(4):84-94. PubMed ID: 9658364
[TBL] [Abstract][Full Text] [Related]
11. The pediatric-modified total neuropathy score: a reliable and valid measure of chemotherapy-induced peripheral neuropathy in children with non-CNS cancers.
Gilchrist LS; Tanner L
Support Care Cancer; 2013 Mar; 21(3):847-56. PubMed ID: 22993026
[TBL] [Abstract][Full Text] [Related]
12. The total neuropathy score: a tool for measuring chemotherapy-induced peripheral neuropathy.
Smith EM; Beck SL; Cohen J
Oncol Nurs Forum; 2008 Jan; 35(1):96-102. PubMed ID: 18192158
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the reliability and consistency of the "malnutrition inflammation score" (MIS) in Mexican adults with chronic kidney disease for diagnosis of protein-energy wasting syndrome (PEW).
González-Ortiz AJ; Arce-Santander CV; Vega-Vega O; Correa-Rotter R; Espinosa-Cuevas Mde L
Nutr Hosp; 2014 Oct; 31(3):1352-8. PubMed ID: 25726233
[TBL] [Abstract][Full Text] [Related]
14. Psychometric evaluation of a new instrument to measure disease self-management of the early stage chronic kidney disease patients.
Lin CC; Wu CC; Wu LM; Chen HM; Chang SC
J Clin Nurs; 2013 Apr; 22(7-8):1073-9. PubMed ID: 22642723
[TBL] [Abstract][Full Text] [Related]
15. Validation of the Patient-Reported Outcomes Measurement Information System (PROMIS)-57 and -29 item short forms among kidney transplant recipients.
Tang E; Ekundayo O; Peipert JD; Edwards N; Bansal A; Richardson C; Bartlett SJ; Howell D; Li M; Cella D; Novak M; Mucsi I
Qual Life Res; 2019 Mar; 28(3):815-827. PubMed ID: 30467780
[TBL] [Abstract][Full Text] [Related]
16. The Perceived Stress Scale-10 (PSS-10) is reliable and has construct validity in Chinese patients with systemic lupus erythematosus.
Sun Y; Gao L; Kan Y; Shi BX
Lupus; 2019 Feb; 28(2):149-155. PubMed ID: 30518288
[TBL] [Abstract][Full Text] [Related]
17. Arabic translation, adaptation and modification of the Dialysis Symptom Index for chronic kidney disease stages four and five.
Almutary H; Bonner A; Douglas C
BMC Nephrol; 2015 Mar; 16():36. PubMed ID: 25884303
[TBL] [Abstract][Full Text] [Related]
18. Development of a health-related quality of life measure for peripheral neuropathy.
Vickrey BG; Hays RD; Beckstrand M
Neurorehabil Neural Repair; 2000; 14(2):93-104. PubMed ID: 15470820
[TBL] [Abstract][Full Text] [Related]
19. The Patient-Reported Outcomes Thermometer-5-Item Scale (5T-PROs): Validation of a New Tool for the Quick Assessment of Overall Health Status in Painful Rheumatic Diseases.
Salaffi F; Di Carlo M; Carotti M; Farah S
Pain Res Manag; 2018; 2018():3496846. PubMed ID: 30425755
[TBL] [Abstract][Full Text] [Related]
20. Comparing neuropathy in multiple myeloma and AL amyloidosis.
Ballegaard M; Nelson LM; Gimsing P
J Peripher Nerv Syst; 2021 Mar; 26(1):75-82. PubMed ID: 33368817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
